SCHEMBL4925449

SCHEMBL4925449

COc1ccccc1Nc1nc(C)c(C(=O)N2CCCC2c2ccccc2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
ALDH1A1 P00352 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
KDM4E B2RXH2 1/20 0.56
SCD5 Q86SK9 6/20 0.47
TRPC3 Q13507 1/20 0.46
TRPC6 Q9Y210 1/20 0.46
ROCK2 O75116 2/20 0.45
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
SCD O00767 3/20 0.45
HSD17B10 Q99714 2/20 0.44
POLB P06746 2/20 0.43
TRPV1 Q8NER1 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 3/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923362 0.94 MAPT (0.52) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4926864 0.82 ALDH1A1 (0.53) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4927878 0.78 MAPT (0.54) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4926963 0.77 KMT2A (0.56) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4924626 0.77 MAPT (0.76) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4919897 0.77 CYP2C9 (0.57) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4924592 0.76 MAPT (0.62) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4923910 0.76 KDM4E (0.58) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4929797 0.75 ALDH1A1 (0.51) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4929805 0.75 ALDH1A1 (0.51) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 MAPT 1729/4885ALDH1A1 1395/4885MEN1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.